Geoff Hall

3.5k total citations
74 papers, 1.5k citations indexed

About

Geoff Hall is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Geoff Hall has authored 74 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Reproductive Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Geoff Hall's work include Ovarian cancer diagnosis and treatment (25 papers), PARP inhibition in cancer therapy (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Geoff Hall is often cited by papers focused on Ovarian cancer diagnosis and treatment (25 papers), PARP inhibition in cancer therapy (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Geoff Hall collaborates with scholars based in United Kingdom, United States and Belgium. Geoff Hall's co-authors include Owen Johnson, Angelina Prima Kurniati, David Hogg, Timothy Perren, Peter J. Selby, Kevin J. Harrington, Richard G. Vile, Alan Melcher, John Chester and Lucy Ziegler and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Geoff Hall

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geoff Hall United Kingdom	22	637	446	317	266	206	74	1.5k
Lewis Hassell United States	24	290 0.5×	231 0.5×	129 0.4×	44 0.2×	170 0.8×	84	1.5k
Ciaran Mannion United States	15	221 0.3×	308 0.7×	71 0.2×	155 0.6×	133 0.6×	34	1.2k
Claire W. Michael United States	26	511 0.8×	559 1.3×	88 0.3×	152 0.6×	846 4.1×	105	2.5k
David Jamieson United Kingdom	20	731 1.1×	502 1.1×	106 0.3×	59 0.2×	383 1.9×	42	1.5k
Adam R. Brentnall United Kingdom	31	1.2k 1.9×	504 1.1×	745 2.4×	55 0.2×	531 2.6×	107	2.6k
Andrew L. Pecora United States	26	1.2k 1.8×	680 1.5×	466 1.5×	63 0.2×	313 1.5×	131	3.3k
Hannah Yang United States	30	1.1k 1.7×	872 2.0×	388 1.2×	497 1.9×	252 1.2×	84	2.8k
Shujie Liao China	20	246 0.4×	432 1.0×	95 0.3×	181 0.7×	41 0.2×	56	1.3k
Kenneth H. Kim United States	23	473 0.7×	587 1.3×	223 0.7×	401 1.5×	232 1.1×	77	2.1k
K. Stephen Suh United States	18	232 0.4×	501 1.1×	45 0.1×	79 0.3×	92 0.4×	33	1.2k

Countries citing papers authored by Geoff Hall

Since Specialization

Citations

This map shows the geographic impact of Geoff Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoff Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoff Hall more than expected).

Fields of papers citing papers by Geoff Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoff Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoff Hall. The network helps show where Geoff Hall may publish in the future.

Co-authorship network of co-authors of Geoff Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Geoff Hall. A scholar is included among the top collaborators of Geoff Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoff Hall. Geoff Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ravikumar, Nishant, et al.. (2025). A Methodological Framework for AI-Assisted Diagnosis of Ovarian Masses Using CT and MR Imaging. Journal of Personalized Medicine. 15(2). 76–76. 2 indexed citations

Guérin‐Charbonnel, Catherine, François C. Bocquet, Sue Cheeseman, et al.. (2024). Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer. ESMO Open. 9(9). 103694–103694. 5 indexed citations

Warrington, Lorraine, Kate Absolom, Paul D. Baxter, et al.. (2024). Quality of life, healthcare usage and finances of UK cancer survivors five years post-diagnosis: a matched controlled study. Journal of Cancer Survivorship.

Allen, Katrina J., et al.. (2023). Artificial intelligence in ovarian cancer histopathology: a systematic review. npj Precision Oncology. 7(1). 83–83. 33 indexed citations

Hall, Geoff, et al.. (2023). Harnessing oncology real-world data with AI. Nature Cancer. 4(12). 1627–1629. 1 indexed citations

Ravikumar, Nishant, et al.. (2023). Radiomics in the evaluation of ovarian masses — a systematic review. Insights into Imaging. 14(1). 165–165. 4 indexed citations

Savage, Richard S., Richard D Neal, C. Johnston, et al.. (2022). Development and validation of multivariable machine learning algorithms to predict risk of cancer in symptomatic patients referred urgently from primary care: a diagnostic accuracy study. BMJ Open. 12(4). e053590–e053590. 4 indexed citations

Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2021). Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative. BMJ Open. 11(9). e046396–e046396. 12 indexed citations

Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2021). Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative. BMJ Open. 11(5). e043442–e043442. 12 indexed citations

10.

Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2019). P2.12-01 Small Cell Lung Cancer (SCLC) Treatment and Survival in the UK: A REAL-Oncology Analysis from the I-O Optimise Initiative. Journal of Thoracic Oncology. 14(10). S812–S812. 1 indexed citations

11.

Snee, M., Sue Cheeseman, Matthew D. Thompson, et al.. (2018). P2.01-91 Treatment Patterns in Patients with Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database. Journal of Thoracic Oncology. 13(10). S700–S700. 4 indexed citations

12.

Ziegler, Lucy, Cheryl Craigs, Robert West, et al.. (2018). Is palliative care support associated with better quality end-of-life care indicators for patients with advanced cancer? A retrospective cohort study. BMJ Open. 8(1). e018284–e018284. 80 indexed citations

13.

Dunwoodie, Elaine, Richard Jones, Alex Newsham, et al.. (2017). Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy. International Journal of Medical Informatics. 103. 32–41. 62 indexed citations

14.

McNeish, Iain A., JA Ledermann, Lisa M. James, et al.. (2014). A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer. Annals of Oncology. 25(10). 1988–1995. 64 indexed citations

15.

Glasspool, Rosalind, Robert Brown, Martin Gore, et al.. (2014). A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer. British Journal of Cancer. 110(8). 1923–1929. 84 indexed citations

16.

Karapanagiotou, Eleni, Victoria Roulstone, Katie Twigger, et al.. (2012). Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies. Clinical Cancer Research. 18(7). 2080–2089. 151 indexed citations

17.

Kottke, Timothy, Geoff Hall, José S. Pulido, et al.. (2010). Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. Journal of Clinical Investigation. 120(5). 1551–1560. 68 indexed citations

18.

Vasudev, Naveen, David A. Cairns, Geoff Hall, et al.. (2010). The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma. Archives of Gynecology and Obstetrics. 284(1). 221–227. 27 indexed citations

19.

Ang, Joo Ern, Riyaz Shah, Ian Coombes, et al.. (2009). A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma. Annals of Oncology. 20(11). 1787–1793. 10 indexed citations

20.

Dent, Judith, Geoff Hall, Nafisa Wilkinson, et al.. (2003). Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation. British Journal of Cancer. 88(10). 1578–1583. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact